Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT00585429

Evaluation of Kidney Disease in Liver Transplant Recipients

Kidney Disease in Advanced Liver Disease Patients: A Study of Kidney Damage by a Urinary Cytokine/Chemokine Multiplex Assay

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
University of Wisconsin, Madison · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A non-invasive urinary test that detects kidney injuries in liver transplant (LT) candidates would be useful for monitoring of kidney damage. Particularly, the ability to predict irreversibility of such renal damage or progressive nature of renal disease in LT candidates would be of importance to determine the need for dual kidney-liver transplantation (KLT) versus LT alone. We will correlate kidney histology with cytokine/chemokine profile expression in the urine as a potentially useful noninvasive diagnostic tool.

Conditions

Timeline

Start date
2006-09-01
Primary completion
2009-12-01
Completion
2009-12-01
First posted
2008-01-03
Last updated
2016-05-12

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00585429. Inclusion in this directory is not an endorsement.